Keep up to date with the latest news and events
September 11, 2017
ALAN supports the #Spot Leukaemia campaign
Read more
September 4, 2017
FDA approval brings first gene therapy to the United States
Read more
September 4, 2017
FDA approves Mylotarg for treatment of acute myeloid leukemia
Read more
September 4, 2017
FDA approves inotuzumab ozogamicin for relapsed or refractory B-cell precursor ALL
Read more
September 4, 2017
Spot Leukaemia Campaign launched by Leukaemia Care UK
Read more